Real-world overall survival (OS) improvements in metastatic urothelial carcinoma (mUC) across three key therapeutic eras.Antonio Cigliola, Andrea Necchi, Michela Piacentini et al.|Journal of Clinical Oncology|2026Cited by 1
Relapsed/refractory clinically advanced (CA) testicular non-seminomatous germ cell tumors (NSGCT): A genomic landscape study.Valentina Tateo, Andrea Necchi, Antonio Cigliola et al.|Journal of Clinical Oncology|2026Cited by 0